Tranexamic acid--its use in controlling dental post-operative bleeding in patients with defective clotting mechanisms.
D000293:Adolescent; D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000150:complications*; D001779:Blood Coagulation Factors; D011232:Chemical Precipitation; D002648:Child; D002675:Child, Preschool; D003080:Cold Temperature; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000209:etiology; D004890:Erythema / Q000209:etiology; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D008744:Methylamines / Q000008:administration & dosage / Q000627:therapeutic use; D006472:Oral Hemorrhage / Q000517:prevention & control*; D012189:Retrospective Studies; D014081:Tooth Extraction / Q000009:adverse effects*
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D003509:Cyclohexanecarboxylic Acids; D008744:Methylamines